Engineered Stem Cell Derived CD4 T Cells Outperform CD8 Counterparts in Leukemia Control
Researchers demonstrated that artificial thymic organoid-derived CAR-iPSC-CD4⁺ T cells sustained prolonged cytotoxicity and resisted functional exhaustion compared to CD8⁺ counterparts ...










